Literature DB >> 307556

Amphibian cells in culture. I. Nutritional studies.

G D Chinchar, J H Sinclair.   

Abstract

Nutritional requirements of amphibian cells in culture were studied for the purpose of modifying a minimal medium in which frog cells could proliferate and which could be used for obtaining drug-resistant and auxotrophic variants. The serum, purine, CO2, and amino acid requirements for ICR 2A (a Rana pipiens haploid cell strain) have been investigated employing two different media: L-15, a nonbicarbonate, amino acid-buffered medium and Eagle's MEM, a bicarbonate-buffered medium. In this paper we present evidence to support the following conclusions: (1) With L-15 as the base medium, 10% fetal calf serum (FCS) supports optimal cell growth during exponential phase. Calf serum, whole, dialyzed, or heat-inactivated, cannot substitute for FCS and, in fact, is inhibitory. (2) Purines are required by ICR 2A cells only if grown in a nonbicarbonate-buffered medium, since the cells under these conditions cannot produce enough endogenous CO2 to support de novo purine synthesis. (3) In addition to the amino acids considered essential for mammalian cells in culture, ICR 2A cells depend upon exogenous asparagine. Glutamine and/or aspartic acid cannot replace the asparagine requirement. However, ICR 2A cells do utilized exogenous glutamine as an oxidative substrate.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 307556     DOI: 10.1002/jcp.1040960309

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  2 in total

1.  Characterization of a new cell line, XL2, obtained from Xenopus laevis and determination of optimal culture conditions.

Authors:  M P Anizet; B Huwe; A Pays; J J Picard
Journal:  In Vitro       Date:  1981-04

2.  Effect of purine supplementation on the growth of salmonid cell lines in different mammalian sera.

Authors:  R C Ganassin; N C Bols
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.